Cymbalta, clinically known as duloxetine, is a prescription medication indicated for the treatment of depression, anxiety, diabetic neuropathic pain and fibromyalgia. It works by increasing the availability of the neurotransmitters serotonin and norepinephrine. It was approved by the U.S. Food and Drug Administration in 2008, and in 2009, there were over 14 million prescriptions dispensed. Patients who stop taking Cymbalta may experience several side effects, and it is recommended that patients taper off of their doses rather than stopping abruptly. Side effects can also vary depending on the size of the dose taken as well as the length of time the patient was taking it.
If you are experiencing serious medical symptoms, seek emergency treatment immediately.
Patients that discontinue Cymbalta may experience several psychological symptoms. These can take place within 24 hours after discontinuation and may last one to three days, but may last up to three weeks. The most common symptoms of atypical antidepressant withdrawal, including Cymbalta, are anxiety and low mood, such as apathy and rebound depression 3. Because Cymbalta strongly affects serotonin, after discontinuation it can take several days for the body's own serotonin system to return to normal. In a study published in the December 2005 issue of the Journal of Affective Disorders, Dr. David Perahia and associates found that up to 50 percent of patients taking Cymbalta for extended periods experienced one or more general withdrawal symptoms including psychiatric disturbances 23. These include anxiety, irritability, crying, depression and nervousness.
- Patients that discontinue Cymbalta may experience several psychological symptoms.
- The most common symptoms of atypical antidepressant withdrawal, including Cymbalta, are anxiety and low mood, such as apathy and rebound depression 3.
Movement and Sensory Symptoms
Mental & Emotional Effects of Ritalin
Patients that stop taking Cymbalta may also experience several movement and sensory disruptions such as:
- electric shock sensations
In the study by Perahia and associates, dizziness is the most common withdrawal symptom, occurring in about 19 percent of patients. Patients also report feeling a pins-and-needles type sensation during withdrawal. In addition, tremor and ringing in the ears are possible symptoms.
There are several other symptoms that may occur from discontinuing Cymbalta. These can include sleep, digestive and other physical disturbances. In the August 2006 issue of American Family Physician, Dr. Christopher Warner and associates stated that patients may experience flu-like symptoms, headache and weakness 1. Patients may experience gastrointestinal disturbances including changes in appetite, nausea and vomiting. Patients may also experience sleep disturbances including insomnia and nightmares. In the study by Perahia and associates, insomnia occurred in around 6 percent of long term patients, while nightmares occurred in around 3 percent of patients. In the same study, anorexia and diarrhea occurred in 2.5 percent of patients. According to eMedTV, headache occurs in around 5 percent of patients that discontinue Cymbalta 3.
Mental & Emotional Effects of Ritalin
Symptoms When Stopping Lexapro
Kamagra Side Effects
Betahistine Hydrochloride Side Effects
Side Effects of Effexor 37.5Mg
What Are the Effects of Taking 1200 mg of Neurontin?
Side Effects of Wellbutrin for Weight Loss
Side Effects of Fastin Diet Pills
How to Discontinue Seroquel
Cymbalta Vs. Prozac
- "American Family Physician"; Antidepressant Discontinuation Syndrome; Dr. Christopher Warner et al.; August 2006
- "Journal of Affective Disorders"; Symptoms Following Abrupt Discontinuation of Duloxetine Treatment in Patients With Major Depressive Disorder; Dr. David Perahia et al.; December 2005
- eMedTV: Cymbalta Withdrawal
- Encyclopedia of Chemistry: Duloxetine
- National Center for Biotechnology Information. PubChem Database. Duloxetine hydrochloride, CID=60834.
- U.S. National Library of Medicine DailyMed. Label: Duloxetine—duloxetine hydrochloride capsule, delayed release. Updated September 9, 2019.
- Osani MC, Bannuru RR. Efficacy and safety of duloxetine in osteoarthritis: a systematic review and meta-analysis. Korean J Intern Med. 2019;34(5):966–973. doi:10.3904/kjim.2018.460
- U.S. National Library of Medicine MedlinePlus. Duloxetine. Updated July 15, 2018.
- Wang ZY, Shi SY, Li SJ, et al. Efficacy and safety of duloxetine on osteoarthritis knee pain: A meta-analysis of randomized controlled trials. Pain Med. 2015;16(7):1373-85. doi:10.1111/pme.12800
Boyd Bergeson has been writing since 2000 and has contributed to published research with the National Institute of Health and The Indian Health Board. Bergeson is currently a mental health professional and has worked as a university instructor, senior medical research assistant, textbook editor, and bicycle shop owner. He has a Master of Science in sociology from Portland State University.